Skip to main content
Clinical Trials/NCT01292941
NCT01292941
Withdrawn
Phase 1

Clinical Study Evaluating Safety of a New Catheter for Urinary Intermittent Catheter in Healthy Volunteers

Coloplast A/S1 site in 1 countryMarch 2011

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Spinal Cord Injury
Sponsor
Coloplast A/S
Locations
1
Primary Endpoint
Discomfort during catheterisation measured by VAS-scale (0-10)
Status
Withdrawn
Last Updated
10 years ago

Overview

Brief Summary

To evaluate discomfort of a new coating and catheter material compared to SpeediCath (SC)

Detailed Description

Intermittent catheterization is the preferred method for emptying the bladder in patients with spinal cord injury and neurogenic bladder dysfunction. Coloplast have developed a new intermittent catheters. In this investigation this new test catheter will be compared with SpeediCat by assessing discomfort and pain associated with catheterization of healthy men. The reason for choosing healthy men is that many catheter users do not have full feeling in their urethra and therefore can not assess the discomfort. 55 healthy men who are ≥ 18 years and have no signs of urinary tract infection and do not have abnormalities, disease or have had operational interventions in the urinary tract will be included. They are recruited through advertisements on the website www.forsoegsperson.dk.

Registry
clinicaltrials.gov
Start Date
March 2011
End Date
June 2011
Last Updated
10 years ago
Study Type
Interventional
Study Design
Crossover
Sex
Male

Investigators

Eligibility Criteria

Inclusion Criteria

  • • ≥18 years
  • Signed informed consent
  • Negative urine stix (erythrocytes, leucocytes and nitrite)

Exclusion Criteria

  • • Abnormalities, diseases or surgical procedures performed in the lower urinary tract

Outcomes

Primary Outcomes

Discomfort during catheterisation measured by VAS-scale (0-10)

Time Frame: 10 measurements in an 11 week period. 10 min after each catheterisation

A subject is assesing a VAS scale after each catheterisation.

Secondary Outcomes

  • Discomfort during urination post catheterisation(10 measurements in an 11 week period. 10 min after each catheterisation)
  • Safety(During the investigation 11 Weeks per subject)
  • Haematuria(10 measurements in an 11 week period. 10 min after each catheterisation)
  • Handling during insertion, withdrawal(10 measurements in an 11 week period. 10 min after each catheterisation)

Study Sites (1)

Loading locations...

Similar Trials